CKMT1A is encoded by the CKMT1A gene, which is located on chromosome 15. The protein exists in two isoenzymes: sarcomeric MtCK and ubiquitous MtCK, encoded by separate genes . The mitochondrial creatine kinase occurs in two different oligomeric forms: dimers and octamers, in contrast to the exclusively dimeric cytosolic creatine kinase isoenzymes .
CKMT1A plays a central role in energy transduction in tissues with large, fluctuating energy demands such as the brain. It catalyzes the reversible transfer of phosphate between ATP and various phosphagens (e.g., creatine phosphate) . This process is essential for maintaining cellular energy homeostasis, especially in tissues with high energy demands .
Impairment in CKMT1A due to oxidative and radical-induced damage has been reported in numerous diseases, including neurodegenerative disorders . Overexpression of CKMT1A is observed in several tumors where high energy consumption is required for proliferation . Diseases associated with CKMT1A include Mitochondrial Complex I Deficiency, Nuclear Type 19, and Reticular Dysgenesis .
The mouse anti-human CKMT1A antibody is a monoclonal antibody used in various research applications, including Western blotting, immunohistochemistry, and immunocytochemistry . It is used to detect CKMT1A protein expression in human, mouse, and rat tissues . The antibody is purified by affinity chromatography and is available in different concentrations for research purposes .